In vitro antileishmanial activity of fluoro-artemisinin derivatives against Leishmania donovani

Biomedicine and Pharmacotherapy

Volumn 62, Issue 7, 2008, Pages 462-465

  Chollet, Constance ^a   Crousse, Benoît ^a   Bories, Christian ^a   Bonnet Delpon, Danièle ^a   Loiseau, Philippe M ^a  

^a IPSIT   (France)

Author keywords

Fluoro artemisinin; In vitro antileishmanial activity; Leishmania donovani

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; ARTEMISININ DERIVATIVE; BB 101; BB 103; BB 134; BB 160; BB 171; BB 174; BB 175; BB 177; BB 178; BB 190; BB 194; BB 199; BB 200; BB 201; BB 203; BB 240; BB 241; BB 242; FLUOROARTEMISININ DERIVATIVE; MILTEFOSINE; SITAMAQUINE;

AMASTIGOTE; ANTIPROTOZOAL ACTIVITY; ARTICLE; CROSS RESISTANCE; DRUG STRUCTURE; IC 50; IN VITRO STUDY; LEISHMANIA DONOVANI; NONHUMAN; PLASMODIUM; PRIORITY JOURNAL; PROMASTIGOTE;

EID: 48449103187     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2008.04.003     Document Type: Article

References (10)

1. Sundar S., and Rai M. Treatment of visceral leishmaniasis. Expert Opin Pharmacother 6 (2005) 2821-2829
2. Sundar S., and Chatterjee M. Visceral leishmaniasis. Current therapeutic modalities. Indian J Med Res 123 (2006) 345-352
3. Seifert K., Matu S., Perez-Victoria J., Castanys S., Gamarro F., and Croft S.L. Characterisation of Leishmania donovani promastigotes resistant to hexadecylphosphocholine (miltefosine). Int J Antimicrob Agents 22 (2003) 380-387
4. Denis M.B., Davis T.M.E., Hewitt S., Incardona S., Nimol K., Fandeur T., et al. Efficacy and safety of dihydroartemisinin-piperaquine (Artekin) in Cambodian children and adults with uncomplicated Falciparum malaria. Clin Infect Dis 35 (2002) 1469-1476
5. Yang D.M., and Liew F.Y. Effects of quinghaosu (artemisinin) and its derivatives on experimental cutaneous leishmaniasis. Parasitology 106 (1993) 7-11
6. Avery M.A., Muraleedharan K.M., Desai P.V., Bandyopadhyaya A.K., Furtado M.M., and Tekwani B.L. Structure-activity relationships of the antimalarial agent artemisinin. Design, synthesis, and CoMFA studies toward the development of artemisinin-based drugs against leishmaniasis and malaria. J Med Chem 46 (2003) 4244-4258
7. Magueur G., Crousse B., Charneau S., Grellier P., Bégué J.P., and Bonnet-Delpon D. Fluoroartemisinin: trifluoromethyl analogues of artemether and artesunate. J Med Chem 47 (2004) 2694-2699
8. Grellepois F., Chorki F., Ourévitch M., Charneau S., Grellier P., McIntosh K.A., et al. Orally active antimalarials: hydrolytically stable derivatives of 10-trifluoromethylanhydrodihydroartemisinin. J Med Chem 47 (2004) 1423-1433
9. Bégué J.P., and Bonnet-Delpon D. Fluoroartemisinins: metabolically more stable antimalarial artemisinin derivatives. ChemMedChem 2 (2007) 608-624
10. Bories C., Cojean S., Huteau F., and Loiseau P.M. Selection and phenotype characterisation of sitamaquine-resistant promastigotes of Leishmania donovani. Biomed Pharmacother 62 (2008) 164-167